-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse Börse DüsseldorfSymbol GS7A-
GlaxosmithklineBörse London Stock ExchangeISIN GB0009252882Symbol GSK
-
GlaxosmithklineBörse Börse FrankfurtISIN GB0009252882 WKN: 940561Symbol GS7
-
GlaxosmithklineBörse Börse BerlinSymbol GS7A
-
GLAXOSMITHKLINE PLC-SPON ADRBörse Börse FrankfurtSymbol GS7A
-
GlaxosmithklineBörse Börse StuttgartSymbol GS7A
-
GlaxosmithklineBörse Börse MünchenSymbol GS7A
-
GlaxosmithklineBörse Gettex System der Börse MünchenSymbol GS7A
-
GLAXOSMITHKLINE PLCBörse Tradegate System der Deutsche Börse AG (60%)Symbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse BerlinSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Quotrix System der Börse DüsseldorfSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse HamburgSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse DüsseldorfSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse MünchenSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse StuttgartSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Gettex System der Börse MünchenSymbol GS7
-
GlaxosmithklineBörse Tradegate System der Deutsche Börse AG (60%)Symbol GS7A
-
GlaxosmithklineBörse Börse HamburgSymbol GS7A
-
GlaxosmithklineBörse Quotrix System der Börse DüsseldorfSymbol GS7A
-
GlaxosmithklineBörse Börse DüsseldorfSymbol GS7A
-
GlaxosmithklineBörse NYSE New York Stock ExchangeISIN GB0009252882 WKN: 940561Symbol GSK
-
GlaxosmithklineBörse Amerikanscher Freiverkehr OTC oder "Pink Sheets"Symbol GSK.LN
-
GlaxoSmithKline PLC ADRBörse NYSE New York Stock ExchangeISIN US37733W1053 WKN: 940610Symbol GSK
-
GLAXOSMITHKLINE PHARMACEUTICALBörse BSE
-
GlaxosmithklineBörse Freiverkehr OTC
-
Symbol GS7
-
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
93.879.525.376 oder 82.199.000.000 oder 81.582.338.640
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
94.066 oder 90.096 Mitarbeiter
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
13.04 oder 18.9
Aktionärsstruktur der GlaxoSmithKline plc
Portrait der Glaxosmithkline Aktie
Das Unternehmen GlaxoSmithKline plc aus Großbritannien beschäftigt 92.081 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Pharma tätig.
Das Unternehmen GlaxoSmithKline plc ist in mehr als 78 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe Select Dividend 30 UCITS ETF (DE) gewichtet Glaxosmithkline mit 6,17% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Glaxosmithkline Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen GlaxoSmithKline plc am höchsten gewichtet ist Insgesamt in 78 ETFs enthalten
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
321 News & Informationen zur Glaxosmithkline Aktie
Epizyme : Announces CEO Succession
Current Chief Executive Officer, Robert Bazemore, to Step Down; Current Board Member, Grant Bogle, Named Incoming CEO
… | August 9, 2021
Epizyme Announces CEO Succession
Epizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies today
Global Pediatric Vaccine Market Research Report 2021: Market is Expected to Reach $49.9 Billion in 2025 – Long-term Forecast to 2030
/PRNewswire/ — The
Drug Delivery Devices Global Markets Report 2021: COVID-19 Impacts, Implications And Growth Factors To 2030
DUBLIN, Aug. 6, 2021 /PRNewswire/ — The “Drug Delivery Devices Global Market Report 2021: COVID-19 Implications and Growth to 2030” report has been added to
10 Biotech Penny Stocks to Buy According to Reddit
In this article, we discuss the 10 biotech penny stocks to buy according to Reddit.
Global Depression Treatment Market (2020 to 2026) – Featuring Allergen, Bausch Health Companies and Lief Therapeutics Among Others
/PRNewswire/ — The
Global Cancer Therapies Market to Reach $204.2 Billion by 2024
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
PlantFuel Solidifies Its Executive Leadership Team, Names New CEO, President And Chairman Of The Board
MISSISSAUGA, ON, Aug. 3, 2021 /PRNewswire/ — PlantFuel Life Inc.(CSE: FUEL) (OTC: BLLXF) (FSE: BR1B) ( “PlantFuel” or the “Company”)has officially named Brad
Sanofi Snaps Up mRNA Specialist for $3.2 Billion Amid Vaccine Success
French healthcare company Sanofi agreed to acquire Translate Bio, a big vote of confidence that the new technology underpinning two successful Covid-19 vaccines holds promise beyond the pandemic.
2 of the best UK stocks to buy
These two top UK stocks have caught my attention in early August trading. Here's why I'd buy them for my shares portfolio.
Barron's Latest Picks And Pans: American Express, GE, GlaxoSmithKline, Intel And More
This weekend's Barron's offers investors an overlooked way to play the coming infrastructure surge. Other featured articles discuss how t…
3 High Ebitda Margin Ratio Stock Picks
GuruFocus Article or News written by Alberto Abaterusso and the topic is about: These businesses appear to be in a good shape from a financial standpoint
Insights on the Targeted Therapeutics Global Market to 2031 – Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
/PRNewswire/ — The “Targeted Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031” report has been added to…
Insights on the Targeted Therapeutics Global Market to 2031 – Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
DUBLIN, July 30, 2021 /PRNewswire/ — The 'Targeted Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 202…
GSK : FDA Approves Mepolizumab For Use In Adults With Chronic Rhinosinusitis With Nasal Polyps
(RTTNews) – GlaxoSmithKline plc (GSK, GSK.L) said that the US Food and Drug Administration has approved Nucala or mepolizumab, a monoclonal antibo…
Bestinfond's Top 2nd-Quarter Trades
GuruFocus Article or News written by Margaret Moran and the topic is about: Spanish fund invests in banking group, sells industrials
GSK Announces FDA Approval For Nucala (mepolizumab) For Use In Adults With Chronic Rhinosinusitis With Nasal Polyps
GlaxoSmithKline plc (GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab), a monoclonal antibody that targets
Keating Investment Counselors Inc Buys GlaxoSmithKline PLC, TotalEnergies SE, Kirkland Lake Gold, Sells Cal-Maine Foods Inc, Honeywell International Inc, Emerson Electric Co
GuruFocus Article or News written by insider and the topic is about:
Essex Savings Bank Buys Verisk Analytics Inc, BlackRock Inc, Citigroup Inc, Sells iShares National Muni Bond ETF, iShares Gold Trust, GlaxoSmithKline PLC
GuruFocus Article or News written by insider and the topic is about:
Bestinfond Buys NatWest Group PLC, Holcim, Laboratorios Farmaceuticos Rovi SA, Sells Befesa SA, Ashtead Group PLC, FLSmidth. A/S
GuruFocus Article or News written by insider and the topic is about:
Monoclonal Antibodies Market to Reach $390.58 Bn, Globally at 10.2% CAGR by 2030: Says AMR
/PRNewswire/ — According to the report the, global monoclonal antibodies market was pegged at $146.64 billion in 2020 and is estimated to reach $390.58…
Global Anti-epileptic Drugs Market to surpass US$ 7,344.9 Million by 2028, Says Coherent Market Insights (CMI)
SEATTLE, July 29, 2021 (GLOBE NEWSWIRE) — Global Anti-epileptic Drugs Market to surpass US$ 7,344.9 Million by 2028, Says Coherent Market Insights (CMI)…
LANNETT expands respiratory pipeline, signs exclusive distribution agreement for generic SPIRIVA® handihaler®
PHILADELPHIA, July 29, 2021 /PRNewswire/ — Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an exclusive U.S. commercia…
GlaxoSmithKline : Q2 2021 results transcript PDF – 168.2KB
GlaxoSmithKline plc
Q2 2021 Results
Presentation to Analysts
Wednesday, 28 July 2021
Iain Mackay… | July 29, 2021
Global Nanobiotechnology Applications And Markets 2021-2026: Molecular Diagnostic, Therapeutics, & Biopharmaceutical Application
DUBLIN, July 27, 2021 /PRNewswire/ — The
WOCHENVORSCHAU: Termine bis 10. August 2021
WOCHENVORSCHAU: Termine bis 10. August 2021 | Nachricht | finanzen.net
Global Polycythemia Vera Therapeutics Market to Surpass US$ 1,516.5 Million by 2028, Says Coherent Market Insights (CMI)
SEATTLE, July 27, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global polycythemia vera therapeutics market is estimated to be…
Global $9.5 Billion Influenza Vaccines Market to 2027
/PRNewswire/ — The “Global Influenza Vaccines Market, Persons Vaccinated, Impact of COVID-19, Company Analysis, Size, Share, Growth, Trends, Major Deals -…
GlaxoSmithKline ( '') (Form 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
GlaxoSmithKline plc
Transaction notification
1.
… | July 26, 2021
WOCHENVORSCHAU: Termine bis 09. August 2021
WOCHENVORSCHAU: Termine bis 09. August 2021 | Nachricht | finanzen.net
GlaxoSmithKline Gets FDA Approval for Shingles Vaccine
By Chris Wack
GlaxoSmithKline Plc said the U.S. Food and Drug Administration has approved Shingrix for the prevention of shingles in adults aged 18 years and older who are or will be at… | July 26, 2021
GlaxoSmithKline : Shingrix approved in the US for prevention of shingles in immunocompromised adults
For media and investors only
Issued: Philadelphia, London
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Shingrix … | July 26, 2021
Shingrix approved in the US for prevention of shingles in immunocompromised adults
/PRNewswire/ — GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant,…
Shingrix approved in the US for prevention of shingles in immunocompromised adults
LONDON and PHILADELPHIA, July 26, 2021 /PRNewswire/ — GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has appr…
Community Financial Services Group, LLC Buys The Toronto-Dominion Bank, Honeywell International Inc, Starbucks Corp, Sells iShares Russell 1000 Growth ETF, Royal Dutch Shell PLC, GlaxoSmithKline PLC
GuruFocus Article or News written by insider and the topic is about:
Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI
Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…
Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI
Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…
Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI
Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…
Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI
Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…
Outlook On The Nutritional Supplements Global Market To 2027 – Trend Forecasts And Growth Opportunities
DUBLIN, July 22, 2021 /PRNewswire/ — The “Global Nutritional Supplements Market 2020-2027 by Ingredient, Product Form, Category, Application, End User,